SCHEMBL7760822

SCHEMBL7760822

NC(=O)C1c2cc[c]cc2CC1NS(=O)(=O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 3/20 0.40
MMP9 P14780 3/20 0.40
MMP13 P45452 3/20 0.40
MMP14 P50281 3/20 0.40
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38
APH1A Q96BI3 2/20 0.38
PSENEN Q9NZ42 2/20 0.38
GAA P10253 2/20 0.37
ALDH1A1 P00352 5/20 0.37
MCOLN2 Q8IZK6 4/20 0.36
MCOLN1 Q9GZU1 4/20 0.36
GFER P55789 1/20 0.36
MMP1 P03956 2/20 0.36
MMP3 P08254 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
THRB P10828 1/20 0.35
MCOLN3 Q8TDD5 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058383 0.81 KDM4E (0.32)
SCHEMBL4058384 0.81 KDM4E (0.32)
SCHEMBL7972730 0.74 HTT (0.37) GAAALDH1A1LMNAMEN1KMT2A
SCHEMBL6198272 0.73 ATM (0.33) NPSR1
SCHEMBL4065727 0.71
SCHEMBL4063260 0.71
SCHEMBL4392496 0.71 KDM1A (0.41) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL4392500 0.71 KDM1A (0.41) ALDH1A1SMN1; SMN2MEN1KMT2A
Hydrochloric Acid SCHEMBL7760855 0.70
SCHEMBL4232585 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097129-A1 N-BENZOCYCLOALKYL-AMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS Novartis AG (CH) 2001-05-09 EP disclosed
US-6197798-B1 INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN NOVARTIS AG (CH) 2001-03-06 US disclosed
WO-2000005201-A1 N-BENZOCYCLOALKYL-AMIDE DERIVATIVES AND THEIR USE AS MEDICAMENTS NOVARTIS AG (CH) 2000-02-03 WO disclosed